Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 17/20 | 1.00 |
| ▸ | CA4 | P22748 | 2/20 | 1.00 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8950360 | 0.87 | CA2 (0.98) | CA2CA4 | |
| SCHEMBL8950278 | 0.86 | CA2 (0.75) | CA2CA4PIK3CA | |
| Hydrochloric Acid SCHEMBL8950327 | 0.85 | CA2 (0.74) | CA2CA4PIK3CA | |
| Hydrochloric Acid SCHEMBL8950342 | 0.82 | CA2 (0.84) | CA2CA4 | |
| SCHEMBL9058131 | 0.80 | CA2 (0.67) | CA2CA4PIK3CDPIK3CAPIK3CB | |
| SCHEMBL8950571 | 0.79 | CA2 (0.65) | CA2CA4 | |
| SCHEMBL8950256 | 0.78 | CA2 (0.64) | CA2CA4CTSB | |
| Hydrochloric Acid SCHEMBL8950440 | 0.78 | CA2 (0.64) | CA2CA4 | |
| SCHEMBL8950259 | 0.77 | CA2 (0.63) | CA2CA4 | |
| Hydrochloric Acid SCHEMBL8950237 | 0.77 | CA2 (0.62) | CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5538966-A | ENZYME INHIBITORS FOR TREATMENT OF GLAUCOMA | ALCON LABORATORIES, INC. (US) | 1996-07-23 | — | — | US | claimed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-5538966-A | ENZYME INHIBITORS FOR TREATMENT OF GLAUCOMA | ALCON LABORATORIES, INC. (US) | 1996-07-23 | — | — | US | disclosed |